Atjaunināt sīkdatņu piekrišanu

Value of Genetic and Genomic Technologies: Workshop Summary [Mīkstie vāki]

  • Formāts: Paperback / softback, 108 pages, height x width: 229x152 mm
  • Izdošanas datums: 29-Dec-2010
  • Izdevniecība: National Academies Press
  • ISBN-10: 0309157714
  • ISBN-13: 9780309157711
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 45,61 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 108 pages, height x width: 229x152 mm
  • Izdošanas datums: 29-Dec-2010
  • Izdevniecība: National Academies Press
  • ISBN-10: 0309157714
  • ISBN-13: 9780309157711
Citas grāmatas par šo tēmu:
Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.

Table of Contents



Front Matter 1 Introduction 2 Tumor-Based Screening for Lynch Syndrome 3 Pharmacogenomic Testing to Guide Warfarin Dosing 4 Genomic Profiling 5 Closing Remarks References Appendix A: Workshop Agenda Appendix B: Speaker Biographical Sketches Appendix C: Lynch Syndrome Topic Brief Appendix D: Warfarin Topic Brief Appendix E: Genomic Profiling Topic Brief
Abbreviations and Acronyms xv
1 Introduction
1(4)
2 Tumor-Based Screening for Lynch Syndrome
5(14)
Colorectal Cancer and Lynch Syndrome Screening
5(3)
Panel Reaction
8(5)
Open Discussion
13(6)
3 Pharmacogenomic Testing to Guide Warfarin Dosing
19(16)
Warfarin Pharmacogenomics
19(4)
Panel Reaction
23(7)
Open Discussion
30(5)
4 Genomic Profiling
35(14)
Genomic Screening for Health Risk Assessment
35(2)
Panel Reaction
37(9)
Open Discussion
46(3)
5 Closing Remarks
49(6)
Research Systems
49(1)
How Much Data Are Enough?
50(1)
Personal Versus Clinical Utility
51(1)
Roundtable Activities
52(1)
Chair's Summary
53(2)
References
55(2)
Appendixes
A Workshop Agenda
57(4)
B Speaker Biographical Sketches
61(10)
C Lynch Syndrome Topic Brief
71(6)
D Warfarin Topic Brief
77(6)
E Genomic Profiling Topic Brief
83